LRP1 and Alzheimer disease: This finding raises concerns about whether Aβ deposition is the initial factor in AD or just the reaction to BBB breakdown and endothelial deficits in Aβ clearance, but it still points out that increasing the LRP1 expression in BECs is beneficial in neurodegenerative diseases.